IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
CM Management, LLC | 200,000 | $910,000 | 0.97% |
Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 445,000 | $2,024,750 | 0.68% |
Logos Global Management LP | 1,000,000 | $4,550,000 | 0.61% |
Soleus Capital Management, L.P. | 1,239,777 | $5,640,985 | 0.52% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,722,711 | $7,838,335 | 0.50% |
Avoro Capital Advisors LLC | 6,700,000 | $30,485,000 | 0.48% |
Rhenman & Partners Asset Management AB | 950,000 | $4,322,500 | 0.47% |
Orbimed Advisors | 4,707,458 | $21,418,934 | 0.46% |
Long Focus Capital Management, LLC | 2,470,521 | $11,240,871 | 0.40% |
Vivo Capital, LLC | 655,057 | $2,980,509 | 0.33% |
Hood River Capital Management LLC | 1,992,335 | $9,065,124 | 0.29% |
External links
This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.